Wolfgang Daum

Luminus Devices, Inc. develops and manufactures solid state lighting solutions. Its products include COB arrays, mid power LEDs, XNOVA cube, high brightness white LEDs, color LEDs, color mix LEDs, UV LEDs, IR LEDs and horticulture LEDs. The company was founded by Alexei Erchak and John D. Joannopoulos in 2002 and is headquartered in Sunnyvale, CA.

Arxan Technologies, Inc. engages in the provision of application security and protection solutions. It offers threat analytics, key and data protection, and application management. The company was founded by J. Eric Davis, John T. Korb, Hoi Chang, John Rice, Richard P. Earley, and Mikhail Atallah in 2001 and is headquartered in San Francisco, CA.

Microsonic Systems, Inc. develops acoustics-based instruments for biotech and pharmaceutical industries. It offers ultrasonic fluid processing devices including Microsonics ST30, a personal deoxyribonucleic acid sample preparations system; and HENDRIX SM100, a ultrasonic fluid processor. The company was founded by Steven Horwitz on August 24, 2004 and is headquartered in San Jose, CA.

PharmaJet, Inc. operates as a medical device company which develops needle-free injection technology. Its products include Tropis needle-free injector device, and flu and polio application. The company was founded by Heather Callender-Potters and Kathleen Callender in 2005 and is headquartered in Golden, CO.

Avancen MOD Corp. provides bedside patient-controlled drug delivery system. The company was founded by Sharon Conley in December 2008 and is headquartered in Mt. Pleasant, SC.

Octant, Inc. operates as a biotechnology company. The company was founded by Sri Kosuri and Ramsey Homsany and is headquartered in Emeryville, CA.

Silicom Ventures LLC (Silicom Ventures) is a venture capital firm founded in 2000 by Gadi Behar. The firm is headquartered in Los Altos, California.

Omniox, Inc. operates as a biopharmaceutical company which develops medicines for hypoxic diseases. Its technology overcomes fundamental biochemical shortcomings of hemoglobin-based and per fluorocarbon oxygen delivery approaches. The company was founded in 2006 by Stephen P. L. Cary, Michael A. Marletta, Jonathan Winger and Elizabeth Marshall Boon and is headquartered in San Carlos, CA.

American Committee for the Weizmann Institute of Science operates as a community of visionary people who advance the partnership between science and philanthropy. It partners with individuals, families, foundations, and the business community to develop philanthropic funding for the institute; educates the American public about the institute’s research; and represents the institute’s interests in the U.S. through the events such as galas, parlor meetings, and luncheons; meetings with institute scientists and campaigns to spread the news of research discovery. The company was founded by Chaim Weizmann in November 1944 and is headquartered in New York, NY.

Assurance Health Services, Inc. provides healthcare services. The company is headquartered in Houston, TX.

Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX.

Amitree, Inc. develops and delivers real estate technology solutions. Its product, Closing Time, is a tool that enables home buyers and their agents navigate the process of buying a home and organizing mission-critical tasks into a checklist that is customized for each buyer's situation. The company as founded by Jonathan Aizen and Paul Knegten in 2012 and is headquartered in San Francisco, CA.

Matternet, Inc. develops drones for its delivery vans. It offers Matternet M2, a drone logistics system that features automatic payload and battery exchange, intelligent routing and monitoring, precision landing, and intuitive command and control. The company was founded by Andreas Raptopoulos, Darlene Damn, Dimitar Pachov, and Paola Santana in 2011 and is headquartered in Menlo Park, CA.

Komodo Health, Inc. provides modern healthcare intelligence. The firm provides data engineering, life sciences, predictive analytics, healthcare, professional services, and machine intelligence. The company was founded by Web Sun and Arif Nathoo in 2014 and is headquartered in San Francisco, CA.

Asimov, Inc. develops and operates software platform for biotechnology. Its platform combines computer-aided design, artificial intelligence, and synthetic biology. The company was founded by Christopher Voigt, Douglas Densmore, Alec Neilson, and Raja Srinivas on March 27, 2017 and is headquartered in Cambridge, MA.

Ada Health GmbH offers a virtual assessment of health symptoms. It specializes in Personal Health, Artificial Intelligence, mHealth and Health Care services. The company was founded by Martin Hirsch, Daniel Nathrath and Claire Novorol and is headquartered in Berlin, Germany.

Wavemaker Three-Sixty Health (Wavemaker 360) is an independent private equity/venture capital firm founded in 2018 by John G. Nackel. The firm is headquartered in Pasadena, California.

xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA.

Aspen Neuroscience, Inc. engages in the provision of neurological treatment services. It offers technologies for patient-specific induced pluripotent stem cell-based therapies. The company was founded by Jeanne Loring and is headquartered in San Diego, CA.

Leaps by Bayer is venture investment unit of Bayer AG (Xetra: BAYN) founded in 2015. The firm is headquartered in Leverkusen, Germany.

Dyno Therapeutics, Inc. engages in the development of therapeutics technologies. It develops technologies for safe, efficient and targeted in vivo delivery of new gene therapies and genome editing therapies. The company was founded by Kelsic Eric David and is headquartered in Watertown, MA.

NaNotics LLC develops nanomedical platform for treating major human and animal diseases. It provides NaNots a new nano-medical platform consisting of in vivo “extractors” that deplete from blood specific molecular signals or signal inhibitors that drive or enable disease progression. The company was founded by Lou Hawthorne and John Dodgson and is headquartered in Mill Valley, CA.

Cellsonics, Inc. engages in development of a next generation single cell isolation. The company is headquartered in Newark, DE.

Immunai, Inc. engages in decoding of immune system to improve health. It offers an immune profiling platform, which is used to advance research and development in checkpoint blockade, cancer cell therapy, and cancer vaccines. The company was founded by Noam Solomon, Luis Voloch, Danny Wells, Ansuman Satpathy and Dan R. Littman in December 2018 and is headquartered in New York, NY.

OMX Ventures LLC (OMX Ventures) is a venture capital firm founded in 2020. The firm is headquartered in Lincolnshire, Illinois.

Enable Medicine, Inc. is a company that aims to make biology more searchable. The company is based in Menlo Park, CA. The company has generated and indexed over a petabyte of data and are studying over 20 diseases across 75 scientific studies. The company works with researchers at institutions worldwide to develop scientific and clinical insights to better understand complex biology. The company's goal is to index and map biology to guide therapeutics discovery and development. The company was founded by Aaron Mayer. The CEO is Sunil Bodapati.

Lakewood Hughes Group LLC (Lakewood Hughes Group) is a private equity firm founded in 2020 by James V. Buzzitta and Gregory J. Corona. The firm is headquartered in Grand Rapids, Michigan.

Delix Therapeutics, Inc. is a clinical-stage neuroscience company that focuses on developing novel neuroplasticity-promoting therapeutics to treat neuropsychiatric and neurological disorders. The company's compounds are small molecules that can induce structural and functional neural changes in targeted areas of the brain. Delix is pioneering a new class of fast-acting outpatient pharmacotherapies and advancing through preclinical and clinical development to bring patients FDA-approved, take-home medicines that will serve several unmet needs. The company is headquartered in Palo Alto, CA, and has subsidiaries in the United States. Delix was founded by David E. Olson, Nick Haft, Nicholas Haft, and Paul A. Conley, and Mark Rus has been the CEO of the company since 2021.

IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation.

Constructive Bio Ltd. is a British biotechnology company that rewrites genomes to create biomolecules that were previously unimaginable. The company is based in Cambridge, UK and is backed by a world-class syndicate of investors including Ahren Innovation Capital, Amadeus Capital Partners, OMX Ventures, and General Inception. The company is creating next-generation therapeutics and industrial solutions while setting the standard for genetic code reprogramming. With a world-class team in synthetic genomics and a passionate commitment to improving health and bioprocessing, Constructive Bio is reimagining the world of biologic therapies by rewriting the genome itself.

Partillion Bioscience Corp. is an American company that specializes in providing a functional single-cell biology reagent platform. The company's nanovial technology allows for single-cell secretion analysis and other research capabilities. The company was founded by Joseph Michael de Rutte and Dino Di Carlo, with Joseph Michael de Rutte serving as CEO since incorporation.

Cancer Commons is a non-profit organization that provides compassionate support for people with advanced or metastatic cancer. The private company is based in Palo Alto. The American company's services include leading-edge care navigation and personalized action plan creation for people with advanced or metastatic cancer. Founded in 2012, the company works one-on-one with patients and caregivers to surface the best-possible action plan for anyone dealing with advanced cancer.